Exemestane

Overview

Exemestane is an oral steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer in postmenopausal women. It works by decreasing the amount of estrogen produced by the body, thus slowing or stopping the growth of breast cancer cells that rely on estrogen to proliferate.

API suppliers (14)

Suppliers of Exemestane backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CURIA SPAIN SAUSpain1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Cipla USA, Inc.USA1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Cipla USA, Inc.USA1 active DMF
• STERLING SPAItaly1 active DMF
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• PERRIGO API LTD
• MAC CHEM PRODUCTS INDIA PVT LTD
• APOTEX PHARMACHEM INC
• TRIFARMA SPA
• ZYFINE DIV CADILA HEALTHCARE LTD
• Dr. Reddy's Laboratories Ltd.India

Chemical identity

IUPAC name

10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione

Canonical SMILES

CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C

InChIKey

BFYIZQONLCFLEV-UHFFFAOYSA-N

Therapeutic areas